Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-31

Clinical Trial Update: Pilocarpine and Brimonidine in Patients With Monofocal Lenses [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a combination of pilocarpine and brimonidine in patients with presbyopia and pseudophakia (monofocal lenses).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine (brimonidine)
  • Pilocarpine (pilocarpine)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Presbyopia, Pseudophakia | EARLY_Phase 1 | Status: UNKNOWN